Cautionary Ann relating to dual listing on Frankfurt Stock Exchange - German Gov plans to legalise cannabis
LABAT AFRICA LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1986/001616/06)
(“Labat Africa” or “the Company”)
ISIN Code: ZAE 000018354 Share code: LAB
CAUTIONARY ANNOUNCEMENT RELATING TO A DUAL LISTING OF LABAT SECURITIES ON THE FRANKFURT
STOCK EXCHANGE - AS GERMAN GOVERNMENT PLANS TO LEGALISE CANNABIS
JSE listed Cannabis group, Labat Africa Limited (Labat), is pleased to announce that its application to list
Labat shares (Equity) on the Frankfurt Stock Exchange (FSE) has been approved by the Deutsche Börse in
an official announcement on Friday, 3 December 2021.
The shares are admitted to trading when the market opens on Monday, 6 December 2021, without
restriction. The application was for the dual listing of the equity (the “Listing”) which shall be quoting under
the ISIN ZAE000018354 on the open market segment “Quotation Board” of the FSE. The Issuer, a company
organized under the laws of South Africa, with the LEI NO 9845000R73DF5EE41J88, will remain primary listed
on the Johannesburg Stock Exchange under the Ticker Symbol “LAB”, with the stock price in Frankfurt linked
to the stock price in Johannesburg. The issuance shall be placed as a private placement.
The listing was handled and successfully concluded by Renell Bank a CRR credit institution within the
meaning of Section 1 Paragraph 3d Sentence 1 KWG in conjunction with Article 4 Paragraph 1 No. 2 of
Regulation (EU) 575/2013 of the European Parliament and of the Council of June 26, 2013.
On Friday, 3 December 2021, Labat announced that it had secured a R300m capital commitment (“Capital
Commitment”) from GR Global Ventures LLC(GRGV) in cash within a maximum of three years in exchange
for new ordinary shares in Labat Africa. In addition, the agreement provides for the issuance of 30 million
warrants to GRGV at a strike price of R0.50 (fifty) cents (more than a 100% premium on the current share
price of Labat Africa).
With Germany’s new coalition government planning to legalise cannabis for medicinal and recreational
purposes, the FSE listing will allow Labat to accelerate its cannabis goals in the European market. The listing
on the FSE will also allow Labat to access capital from retail and institutional investors worldwide, and will
also allow new investors to have access to Labat’s shares.
The legalisation of cannabis in Germany is said to represent the largest cannabis market in Europe.
According to reports in the leading German publication, Der Spiegel, the parties have now managed to
agree and align on the legalization of cannabis for wellness and recreational consumption.
Shareholders are advised to exercise caution until a further announcement is made, in order for Labat and
its shareholders to assess the impact of this listing on the FSE.
6 December 2021
AcaciaCap Advisors Proprietary Limited
Date: 06-12-2021 02:03:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.